How much binding affinity can be gained by filling a cavity?

Yuko Kawasaki, Eduardo E. Chufan, Virginie Lafont, Koushi Hidaka, Yoshiaki Kiso, Mario L Amzel, Ernesto I Freire

Research output: Contribution to journalArticle

Abstract

Binding affinity optimization is critical during drug development. Here, we evaluate the thermodynamic consequences of filling a binding cavity with functionalities of increasing van der Waals radii (-H, -F, -Cl, and CH 3) that improve the geometric fit without participating in hydrogen bonding or other specific interactions. We observe a binding affinity increase of two orders of magnitude. There appears to be three phases in the process. The first phase is associated with the formation of stable van der Waals interactions. This phase is characterized by a gain in binding enthalpy and a loss in binding entropy, attributed to a loss of conformational degrees of freedom. For the specific case presented in this article, the enthalpy gain amounts to -1.5 kcal/mol while the entropic losses amount to +0.9 kcal/mol resulting in a net 3.5-fold affinity gain. The second phase is characterized by simultaneous enthalpic and entropic gains. This phase improves the binding affinity 25-fold. The third phase represents the collapse of the trend and is triggered by the introduction of chemical functionalities larger than the binding cavity itself [CH(CH3)2]. It is characterized by large enthalpy and affinity losses. The thermodynamic signatures associated with each phase provide guidelines for lead optimization.

Original languageEnglish (US)
Pages (from-to)143-151
Number of pages9
JournalChemical Biology and Drug Design
Volume75
Issue number2
DOIs
StatePublished - Feb 2010

Fingerprint

Thermodynamics
Enthalpy
Entropy
Hydrogen Bonding
Guidelines
Pharmaceutical Preparations
Hydrogen bonds
Lead

Keywords

  • Binding affinity
  • Enthalpy
  • Entropy
  • Halogens
  • Isothermal titration calorimetry
  • Thermodynamic optimization

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine

Cite this

How much binding affinity can be gained by filling a cavity? / Kawasaki, Yuko; Chufan, Eduardo E.; Lafont, Virginie; Hidaka, Koushi; Kiso, Yoshiaki; Amzel, Mario L; Freire, Ernesto I.

In: Chemical Biology and Drug Design, Vol. 75, No. 2, 02.2010, p. 143-151.

Research output: Contribution to journalArticle

Kawasaki, Yuko ; Chufan, Eduardo E. ; Lafont, Virginie ; Hidaka, Koushi ; Kiso, Yoshiaki ; Amzel, Mario L ; Freire, Ernesto I. / How much binding affinity can be gained by filling a cavity?. In: Chemical Biology and Drug Design. 2010 ; Vol. 75, No. 2. pp. 143-151.
@article{6ea0ab0708a14e7f86041d95d413a086,
title = "How much binding affinity can be gained by filling a cavity?",
abstract = "Binding affinity optimization is critical during drug development. Here, we evaluate the thermodynamic consequences of filling a binding cavity with functionalities of increasing van der Waals radii (-H, -F, -Cl, and CH 3) that improve the geometric fit without participating in hydrogen bonding or other specific interactions. We observe a binding affinity increase of two orders of magnitude. There appears to be three phases in the process. The first phase is associated with the formation of stable van der Waals interactions. This phase is characterized by a gain in binding enthalpy and a loss in binding entropy, attributed to a loss of conformational degrees of freedom. For the specific case presented in this article, the enthalpy gain amounts to -1.5 kcal/mol while the entropic losses amount to +0.9 kcal/mol resulting in a net 3.5-fold affinity gain. The second phase is characterized by simultaneous enthalpic and entropic gains. This phase improves the binding affinity 25-fold. The third phase represents the collapse of the trend and is triggered by the introduction of chemical functionalities larger than the binding cavity itself [CH(CH3)2]. It is characterized by large enthalpy and affinity losses. The thermodynamic signatures associated with each phase provide guidelines for lead optimization.",
keywords = "Binding affinity, Enthalpy, Entropy, Halogens, Isothermal titration calorimetry, Thermodynamic optimization",
author = "Yuko Kawasaki and Chufan, {Eduardo E.} and Virginie Lafont and Koushi Hidaka and Yoshiaki Kiso and Amzel, {Mario L} and Freire, {Ernesto I}",
year = "2010",
month = "2",
doi = "10.1111/j.1747-0285.2009.00921.x",
language = "English (US)",
volume = "75",
pages = "143--151",
journal = "Chemical Biology and Drug Design",
issn = "1747-0277",
publisher = "Blackwell",
number = "2",

}

TY - JOUR

T1 - How much binding affinity can be gained by filling a cavity?

AU - Kawasaki, Yuko

AU - Chufan, Eduardo E.

AU - Lafont, Virginie

AU - Hidaka, Koushi

AU - Kiso, Yoshiaki

AU - Amzel, Mario L

AU - Freire, Ernesto I

PY - 2010/2

Y1 - 2010/2

N2 - Binding affinity optimization is critical during drug development. Here, we evaluate the thermodynamic consequences of filling a binding cavity with functionalities of increasing van der Waals radii (-H, -F, -Cl, and CH 3) that improve the geometric fit without participating in hydrogen bonding or other specific interactions. We observe a binding affinity increase of two orders of magnitude. There appears to be three phases in the process. The first phase is associated with the formation of stable van der Waals interactions. This phase is characterized by a gain in binding enthalpy and a loss in binding entropy, attributed to a loss of conformational degrees of freedom. For the specific case presented in this article, the enthalpy gain amounts to -1.5 kcal/mol while the entropic losses amount to +0.9 kcal/mol resulting in a net 3.5-fold affinity gain. The second phase is characterized by simultaneous enthalpic and entropic gains. This phase improves the binding affinity 25-fold. The third phase represents the collapse of the trend and is triggered by the introduction of chemical functionalities larger than the binding cavity itself [CH(CH3)2]. It is characterized by large enthalpy and affinity losses. The thermodynamic signatures associated with each phase provide guidelines for lead optimization.

AB - Binding affinity optimization is critical during drug development. Here, we evaluate the thermodynamic consequences of filling a binding cavity with functionalities of increasing van der Waals radii (-H, -F, -Cl, and CH 3) that improve the geometric fit without participating in hydrogen bonding or other specific interactions. We observe a binding affinity increase of two orders of magnitude. There appears to be three phases in the process. The first phase is associated with the formation of stable van der Waals interactions. This phase is characterized by a gain in binding enthalpy and a loss in binding entropy, attributed to a loss of conformational degrees of freedom. For the specific case presented in this article, the enthalpy gain amounts to -1.5 kcal/mol while the entropic losses amount to +0.9 kcal/mol resulting in a net 3.5-fold affinity gain. The second phase is characterized by simultaneous enthalpic and entropic gains. This phase improves the binding affinity 25-fold. The third phase represents the collapse of the trend and is triggered by the introduction of chemical functionalities larger than the binding cavity itself [CH(CH3)2]. It is characterized by large enthalpy and affinity losses. The thermodynamic signatures associated with each phase provide guidelines for lead optimization.

KW - Binding affinity

KW - Enthalpy

KW - Entropy

KW - Halogens

KW - Isothermal titration calorimetry

KW - Thermodynamic optimization

UR - http://www.scopus.com/inward/record.url?scp=74549115297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74549115297&partnerID=8YFLogxK

U2 - 10.1111/j.1747-0285.2009.00921.x

DO - 10.1111/j.1747-0285.2009.00921.x

M3 - Article

C2 - 20028396

AN - SCOPUS:74549115297

VL - 75

SP - 143

EP - 151

JO - Chemical Biology and Drug Design

JF - Chemical Biology and Drug Design

SN - 1747-0277

IS - 2

ER -